Publication: Eculizumab for atypical hemolytic-uremic syndrome. How long should we maintain it?
No Thumbnail Available
Identifiers
Date
2019-02-21
Authors
Naranjo Muñoz, Javier
Garcia Garcia-Doncel, Ana
Montero Escobar, María Elisa
Villanego Fernandez, Florentino
Millán Ortega, Irene
Ceballos Guerrero, Manuel
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Description
MeSH Terms
Adult
Antibodies, Monoclonal, Humanized
Atypical Hemolytic Uremic Syndrome
Complement Inactivating Agents
Humans
Male
Time Factors
Antibodies, Monoclonal, Humanized
Atypical Hemolytic Uremic Syndrome
Complement Inactivating Agents
Humans
Male
Time Factors